Irinotecan liposome combined with anlotinib as second-line treatment in patients with small cell lung cancer (SCLC). Correlation of LDH and α-HBDH with PFS Spearman's correlation-detailed format. PFS ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback